Skip to content
10-Q

Quarterly Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-24-032266

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q2 2024 · Jun 30, 2024 $1.52M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $2.55M
Current Liabilities Q2 2024 · Jun 30, 2024 $9.15M
Current Liabilities Q2 2024 · Dec 31, 2023 $8.89M
Total Liabilities Q2 2024 · Jun 30, 2024 $9.19M
Total Liabilities Q2 2024 · Dec 31, 2023 $8.94M
Current Assets Q2 2024 · Jun 30, 2024 $1.53M
Current Assets Q2 2024 · Dec 31, 2023 $2.57M
Total Assets Q2 2024 · Jun 30, 2024 $2.22M
Total Assets Q2 2024 · Dec 31, 2023 $3.23M
Shares Diluted Q2 2024 · Jun 30, 2023 1.03B sh
Shares Diluted Q2 2024 · Jun 30, 2023 1.03B sh
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$668.04K
Stockholders Equity Q2 2024 · Jun 30, 2023 −$4.51M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$4.04M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$3.52M
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Sga Expense Q2 2024 · Jun 30, 2023 $220.67K
Sga Expense Q2 2024 · Jun 30, 2023 $431.77K
Rd Expense Q2 2024 · Jun 30, 2023 $57.04K
Rd Expense Q2 2024 · Jun 30, 2023 $126.13K
Net Income Q2 2024 · Jun 30, 2023 −$589.09K
Net Income Q2 2024 · Jun 30, 2023 −$1.16M
Operating Income Q2 2024 · Jun 30, 2023 −$480.68K
Operating Income Q2 2024 · Jun 30, 2023 −$967.24K
Stock Issued Q2 2024 · Feb 16, 2023 2.43M sh